FDA weighs over-the-counter approval of Singulair

Wednesday, April 30, 2014 - 08:30 in Health & Medicine

WASHINGTON (AP) -- Federal health regulators are weighing the risks of permitting Merck to sell its prescription respiratory pill Singulair as an over-the-counter medicine for allergies....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net